Evaluation of dystrophic dog pathology by fat‐suppressed T2‐weighted imaging
暂无分享,去创建一个
Akinori Nakamura | Shin'ichi Takeda | A. Nakamura | S. Takeda | M. Fujita | H. Orima | Masanori Kobayashi | Daisuke Hasegawa | Michio Fujita | Hiromitsu Orima | D. Hasegawa | Masanori Kobayashi
[1] M. Ladd,et al. Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI , 2004, Neuromuscular Disorders.
[2] A. Nakamura,et al. Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies , 2006, BMC cardiovascular disorders.
[3] K. Davies,et al. Utrophin upregulation in Duchenne muscular dystrophy. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[4] W. D. Bidgood,et al. Fat tissue and fat suppression. , 1993, Magnetic resonance imaging.
[5] J. Dunn,et al. Quantitative magnetic resonance imaging of the mdx mouse model of Duchenne muscular dystrophy , 1999, Muscle & nerve.
[6] I. Nonaka,et al. Canine X-linked muscular dystrophy in Japan (CXMDJ). , 2003, Experimental animals.
[7] K. Tominaga,et al. Significance of Frequency-Selective Fat Saturation T2-Weighted MR Images for the Detection of Bone Marrow Edema in the Mandibular Condyle , 2004, Cranio : the journal of craniomandibular practice.
[8] Y. Tanabe,et al. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse , 2004, Acta Neuropathologica.
[9] F. Muntoni,et al. Muscular weakness in the mdx mouse , 1993, Journal of the Neurological Sciences.
[10] M. Zanca,et al. Characterization in vivo of muscle fiber types by magnetic resonance imaging. , 1998, Magnetic resonance imaging.
[11] T Ishihara,et al. Muscle damage progression in Duchenne muscular dystrophy evaluated by a new quantitative computed tomography method. , 1993, Archives of physical medicine and rehabilitation.
[12] M. Koenig,et al. Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.
[13] L. L. Cook,et al. Pathology‐guided MR analysis of acute and chronic experimental allergic encephalomyelitis spinal cord lesions at 1.5T , 2005, Journal of magnetic resonance imaging : JMRI.
[14] B. Cooper,et al. Canine X-linked muscular dystrophy An animal model of Duchenne muscular dystrophy: Clinical studies , 1988, Journal of the Neurological Sciences.
[15] K. Campbell,et al. Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption , 1997, The Journal of cell biology.
[16] S. Majumdar,et al. Quantitative MR relaxometry study of muscle composition and function in duchenne muscular dystrophy , 1994, Journal of magnetic resonance imaging : JMRI.
[17] A. Baxter,et al. In Vitro Histamine Release Induced by Magnetic Resonance Imaging and Iodinated Contrast Media , 1993, Investigative Radiology.
[18] T. Partridge,et al. THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATION , 1988, Neuropathology and applied neurobiology.
[19] P. Carlier,et al. Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging , 2007, Neuromuscular Disorders.
[20] K. Katada,et al. [A case of anaphylactic shock following the administration of Gd-DTPA]. , 1993, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.
[21] H. Kalimo,et al. Magnetic Resonance Imaging and Magnetization Transfer in Experimental Myonecrosis in the Rat , 1995, Magnetic resonance in medicine.
[22] J. Certaines,et al. In vivo evidence of abnormal mechanical and oxidative functions in the exercised muscle of dystrophic hamsters by 31P-NMR , 1995, Journal of the Neurological Sciences.
[23] B. Chance,et al. Canine X‐linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy , 1991, Muscle & nerve.
[24] G. Radda,et al. A 31P-NMR study of muscle exercise metabolism in mdx mice: Evidence for abnormal pH regulation , 1992, Journal of the Neurological Sciences.
[25] K. Campbell,et al. Contrast agent‐enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy , 2000, Magnetic resonance in medicine.
[26] F. Mastaglia,et al. Morphological changes in dystrophic muscle. , 1980, British medical bulletin.
[27] D Matthaei,et al. 1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.
[28] J. Ervasti,et al. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle , 1990, Nature.
[29] Wilbur L. Smith,et al. Magnetic resonance imaging of children with Duchenne muscular dystrophy , 2006, Pediatric Radiology.
[30] Francesco Muntoni,et al. Muscle MRI in inherited neuromuscular disorders: Past, present, and future , 2007, Journal of magnetic resonance imaging : JMRI.
[31] L. Martí-Bonmatí,et al. The value of fat-suppressed T2 or STIR sequences in distinguishing lipoma from well-differentiated liposarcoma , 2003, European Radiology.
[32] Vicente Gilsanz,et al. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. , 2008, AJR. American journal of roentgenology.
[33] N. Rofsky,et al. Nonspecificity of short inversion time inversion recovery (STIR) as a technique of fat suppression: pitfalls in image interpretation. , 1996, AJR. American journal of roentgenology.
[34] Y. Tateno,et al. Protron spin‐lattice relaxation time of duchenne dystrophy skeletal muscle by magnetic resonance imaging , 1988, Muscle & nerve.
[35] G. Radda,et al. Exercise metabolism in Duchenne muscular dystrophy: a biochemical and [31P]-nuclear magnetic resonance study of mdx mice , 1993, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[36] Eric P. Hoffman,et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs , 1988, Nature.
[37] A. Connolly,et al. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging , 2005, Skeletal Radiology.
[38] W J Manning,et al. Factors in myocardial “Perfusion” imaging with ultrafast MRI and Gd‐DTPA administration , 1991, Magnetic resonance in medicine.
[39] H. Moser,et al. Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention , 2004, Human Genetics.
[40] K. Campbell. Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage , 1995, Cell.
[41] J. E. Anderson,et al. Magnetic resonance imaging of regenerating and dystrophic mouse muscle. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[42] B. Cooper,et al. Canine X-linked muscular dystrophy: Morphologic lesions , 1990, Journal of the Neurological Sciences.
[43] A. Nakamura,et al. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[44] A. Drevelegas,et al. Lipomatous tumors of soft tissue: MR appearance with histological correlation. , 2004, European journal of radiology.
[45] Akinori Nakamura,et al. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle , 2008, BMC musculoskeletal disorders.
[46] G. Walter,et al. Noninvasive monitoring of gene correction in dystrophic muscle , 2005, Magnetic resonance in medicine.